Jounce Therapeutics to Present Program Updates at AACR Annual Meeting 2016
Cambridge, Mass. – March 16, 2016 – Jounce Therapeutics, Inc., a company focused on the discovery and development of novel cancer immunotherapies coupled to patient enrichment strategies, today announced that advances within the company’s immunooncology pipeline will be presented during two poster presentations on Sunday, April 17, 2016 at the American Association of Cancer Research (AACR) Annual Meeting 2016. The meeting is being held April 16-20, 2016 at the Ernest N. Morial Convention Center in New Orleans.
Home / Portfolio Company News / Jounce Therapeutics to Present Program Updates at AACR Annual Meeting 2016